BlackTreeCVE Intelligence
← Back to the CVE catalogue
Full vulnerability report · 2015
CVE-2014-5406High confidence

Hospira LifeCare PCA Infusion System

Hospira · LifeCare PCA Infusion System

7.6HighCVSS 2.0
Recommended action
Within 7 days

High technical severity; prioritise exposed affected systems while verifying vendor guidance.

Patch available
R
Operational reassessment

Published severity in operational context

Open reassessment dashboard →
Published severityHighOperational priority:High, unchanged from published severity.unchanged

Evidence used

  • No CISA KEV confirmation is currently recorded.
  • EPSS is 1.24% for the current model date.

Compensating controls

  • Validate the affected product branch and deploy the verified fixed release.
  • Restrict local access and enforce least privilege on affected hosts.
  • Monitor vendor guidance and exploitation sources for a material change.

Verification

  1. Confirm that the asset runs Hospira LifeCare PCA Infusion System and falls inside the recorded affected range.
  2. Verify the installed build against the product-specific fixed version after deployment.
  3. Validate exposure, authentication requirements and compensating controls in the actual environment.
  4. Reopen this reassessment when CVSS, KEV, EPSS, exploit evidence or remediation changes.
Mitigation target: Within 30 daysRemediation target: Within 180 days

This automated reassessment organises public evidence. It does not know asset exposure, business impact or control effectiveness and does not replace CVSS or a human risk decision.

Optional official sources

National CERT insights
?CERT means Computer Emergency Response Team; CSIRT is the closely related term Computer Security Incident Response Team.

Choose official national sources for this report. Each advisory shows its original language. Your selection is remembered on this device and included in shared links.

Official European source

ENISA European Vulnerability Database

Official EUVD identifiers, advisory evidence and known-exploited context. Missing fields are not treated as evidence of low risk.

1 current
ENISA EUVD identifier

EUVD-2014-5294

No EUVD known-exploited evidence

ENISA has published the identifier mapping but no EUVD description has been stored yet.

EUVD state
Present in the current official mapping
Known exploitation
Not present in the current ENISA EUVD known-exploited dataset. This is not proof of no exploitation.
ENISA score
Not supplied in the stored EUVD record
Advisory evidence
No linked advisory details stored yet
Recommended actionWithin 7 days

High technical severity; prioritise exposed affected systems while verifying vendor guidance.

Patch available
01

What, why and how

The Hospira LifeCare PCA Infusion System before 7.0 does not validate network traffic associated with sending a (1) drug library, (2) software update, or (3) configuration change, which allows remote attackers to modify settings or medication data via packets on the (a) TELNET, (b) HTTP, (c) HTTPS, or (d) UPNP port. NOTE: this issue might overlap CVE-2015-3459.

What

The Hospira LifeCare PCA Infusion System before 7.0 does not validate network traffic associated with sending a (1) drug library, (2) software update, or (3) configuration change, which allows remote attackers to modify settings or medication data via packets on the (a) TELNET, (b) HTTP, (c) HTTPS, or (d) UPNP port. NOTE: this issue might overlap CVE-2015-3459.

Why

The product does not sufficiently verify the origin or authenticity of data, in a way that causes it to accept invalid data.

How

An attacker operating through the affected interface may attempt exploitation when the stated preconditions are met. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.

What

The Hospira LifeCare PCA Infusion System before 7.0 does not validate network traffic associated with sending a (1) drug library, (2) software update, or (3) configuration change, which allows remote attackers to modify settings or medication data via packets on the (a) TELNET, (b) HTTP, (c) HTTPS, or (d) UPNP port. NOTE: this issue might overlap CVE-2015-3459.

Why

The product does not sufficiently verify the origin or authenticity of data, in a way that causes it to accept invalid data.

How

An attacker operating through the affected interface may attempt exploitation when the stated preconditions are met. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.

02

Exploit reality and attack path

CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.

Observed exploitation
?Confirmed exploitation and public exploit material are separate signals. Attacks can occur without public proof-of-concept or exploit code.
No confirmed evidence

No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.

Public PoC / exploit material
?Confirmed exploitation and public exploit material are separate signals. Attacks can occur without public proof-of-concept or exploit code.
None recorded

No exploit-tagged reference or CISA SSVC proof-of-concept state is currently recorded. Research may still exist outside the structured feeds.

Likely attack path
the affected interface → Insufficient Verification of Data Authenticity → cause the confidentiality, integrity or availability impact described by the vendor
Attack surface
Unspecified
Privileges required
None: unauthenticated exploitation is possible
User interaction
Not stated in the selected CVSS metric
Attack complexity
High: exploitation depends on specific conditions
Security boundary
Not stated in the selected CVSS metric
Weakness
?CWE means Common Weakness Enumeration: a standard category for the underlying weakness.
CWE-345 ↗

CWE-345: Insufficient Verification of Data Authenticity. The product does not sufficiently verify the origin or authenticity of data, in a way that causes it to accept invalid data.

CVSS vector
?CVSS means Common Vulnerability Scoring System. The vector records the metric values used to calculate technical severity.
AV:N/AC:H/Au:N/C:C/I:C/A:C
Post-exploitation / living off the land
No specific living-off-the-land technique is confirmed in the structured sources. Monitor normal administration tools for activity inconsistent with the affected service's baseline.
UnauthenticatedCWE-345
A

Official authority intelligence

Only matched European and national findings are included. Language selectors and unavailable sources are omitted.

03

Patch and workaround

Operational remediation based on structured source evidence.

Status
?Patch availability is based on structured fixed-version fields and authoritative update references. If no fix is verified, check the vendor advisory before making a change.
Patch available
Affected
LifeCare PCA Infusion System: ≤ 5.0
Fixed
LifeCare PCA Infusion System: 7.0
Action
Review the linked authoritative reference and apply the recorded fixed release appropriate to the affected product branch.
Workaround
No verified workaround is recorded. Limit untrusted access and use least privilege until authoritative guidance is available.
04

Evidence and provenance

Published 6 Jul 2015 · Last source change 3 Nov 2025, 18:34 UTC · CWE-345 · Insufficient Verification of Data Authenticity

CVE recordCVE.org · 5.2
CVSS sourceCNA
EPSS source
?The date BlackTree first stored a score for this CVE from the daily FIRST EPSS feed.
FIRST · tracked since 2026-09-01
European sourceENISA EUVD · EUVD-2014-5294
Product sourceCNA
Remediation sourceCVE/CNA references
CWE sourceCNA
NVD statusNVD modified after enrichment

Core structured fields are present and their contributing authorities are shown above.

Material change intelligence

What changed after publication

View recent updates ↗
  1. ENISA EUVD mappingEUVD-2014-5294 was added to the official ENISA EUVD mapping for this CVE.
    Before
    not recorded
    After
    {"euvdId":"EUVD-2014-5294"}
    ENISA EUVD ↗
  2. Catalogue recordCVE added to the BlackTree catalogue.
    CNA ↗
Material fields only · duplicate refreshes suppressed · history retained for the configured operational retention period
CVE published
Fixed release or patch reference recorded
ENISA EUVD · EUVD-2014-5294↗CVE authority or vendor reference↗Official CVE record (CNA and ADP data)↗NVD record↗
Technical terms and abbreviations used in this report
CVE
Common Vulnerabilities and Exposures: the public identifier for one disclosed vulnerability.
CVSS
Common Vulnerability Scoring System: a technical severity framework; it is not patching priority by itself.
EPSS
Exploit Prediction Scoring System: FIRST's estimate of the probability that exploitation activity will be observed in the next 30 days; it is a forecast, not confirmation.
CWE
Common Weakness Enumeration: the standard category describing the underlying software or hardware weakness.
CNA
CVE Numbering Authority: an organisation authorised to assign and publish CVE records.
CISA ADP
Cybersecurity and Infrastructure Security Agency Authorized Data Publisher: structured enrichment added to a CVE record.
NVD
National Vulnerability Database: NIST's enrichment service for CVE records.
CERT / CSIRT
A computer security incident response team that publishes warnings or coordinates incident response.
PoC
Proof of concept: public material that demonstrates or helps reproduce exploitation.
CSAF
Common Security Advisory Framework: a machine-readable format for security advisories.
LoTL
Living off the land: abuse of legitimate tools or system functions during an attack.
Free version - for non-commercial use only.CVE-2014-5406 · cve.blacktree.nl